Interestingly, the case marked with a solid arrow in Figure 6a had a somatic KRAS G>A substitution (Gly12Asp mutation, ref. [21]) in tumor tissue, supporting the hypothesis of Svrcek et al. [47]. Here, KRAS is linked to neoplasm.